Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2007

01-09-2007 | Pre-clinical Study

Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications

Authors: Reinou S. Groen, A. Wolter J. Oosterhuis, James E. Boers

Published in: Breast Cancer Research and Treatment | Issue 1/2007

Login to get access

Abstract

Background

The objective was to determine the additional value of pathologic examination using three-level sectioning and immunocytokeratin (ICK) staining of sentinel lymph node (SN) biopsies in cT1-2N0M0 breast carcinoma patients regarding lymph node staging and eligibility of systemic therapy taking primary tumor characteristics in account.

Methods

SN slides of 277 patients out of a total group of 961 patients known to have tumor-positive SNs detected by three-level sectioning and ICK staining were re-examined. Haematoxylin-eosin (HE) slide level three was scanned for tumor deposits, and when present, extra capsular extension, maximum tumor diameter and number of positive SNs was noted. In addition, slides of the axillary dissection of non-SNs were reviewed, with determination of metastasis size and number of positive non-SNs. Primary tumor characteristics (grade, diameter, estrogen receptor) were recorded.

Results

In the single-HE examination, 26 cases SN micrometastasis and 6 macrometastasis were missed, 3 cases of micrometastasis were incorrectly classified as isolated tumor cells, and 9 patients with macrometastasis were misclassified as micrometastasis. In addition, in the tumor-negative single-HE examination, additional axillary lymph node dissection (ALND) revealed 6 cases of non-SN metastasis. Taking primary tumor factors into account for adjuvant systemic therapy, 21 patients would have been denied the choice for systemic therapy if single-HE examination was carried out only.

Conclusions

Single-HE examination of SN may result in a reduction of locoregional and systemic treatment according to treatment guidelines then current in the Netherlands.
Literature
1.
go back to reference Weaver DL (2005) Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America. Histopathology 46:702–706PubMedCrossRef Weaver DL (2005) Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America. Histopathology 46:702–706PubMedCrossRef
2.
go back to reference Cserni G, Gregori D, Merletti F, Sapino A, Mano MP, Ponti A, Sandrucci S, Baltas B, Bussolati G (2004) Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91:1245–1252PubMedCrossRef Cserni G, Gregori D, Merletti F, Sapino A, Mano MP, Ponti A, Sandrucci S, Baltas B, Bussolati G (2004) Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91:1245–1252PubMedCrossRef
3.
4.
go back to reference Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP (2005) American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 30:7703–7720CrossRef Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP (2005) American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 30:7703–7720CrossRef
5.
go back to reference Turner RR, Giuliano AE, Hoon DS, Glass EC, Krasne DL (2001) Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg 25:798–805PubMedCrossRef Turner RR, Giuliano AE, Hoon DS, Glass EC, Krasne DL (2001) Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg 25:798–805PubMedCrossRef
6.
go back to reference Schrenk P, Konstantiniuk P, Wolfl S (2005) Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 92:7007–7013CrossRef Schrenk P, Konstantiniuk P, Wolfl S (2005) Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 92:7007–7013CrossRef
7.
go back to reference Nos C, Harding-MacKean C, Freneaux P (2003) Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 90:1354–1360PubMedCrossRef Nos C, Harding-MacKean C, Freneaux P (2003) Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 90:1354–1360PubMedCrossRef
8.
go back to reference The CBO Website. http://www.cbo.nl/product/richtlijnen/pdf/mammacdiagscr [ 24 January 2005] The CBO Website. http://​www.​cbo.​nl/​product/​richtlijnen/​pdf/​mammacdiagscr [ 24 January 2005]
9.
go back to reference The CBO Website. http://www.cbo.nl/product/richtlijnen/folder20021023121843/mammac_rl_2005.pdf/view [24 January 2005] The CBO Website. http://​www.​cbo.​nl/​product/​richtlijnen/​folder2002102312​1843/​mammac_​rl_​2005.​pdf/​view [24 January 2005]
10.
go back to reference Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner J, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA (2002) European Working Group for Breast Screening Pathology: Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation og guidelines. Eur J Cancer 39:1654–1667CrossRef Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner J, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA (2002) European Working Group for Breast Screening Pathology: Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation og guidelines. Eur J Cancer 39:1654–1667CrossRef
11.
go back to reference Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV (2001) Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treatment 70:81–88CrossRef Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV (2001) Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treatment 70:81–88CrossRef
12.
go back to reference Smidt ML, Janssen CM, Kuster DM, Bruggink ED, Strobbe LJ (2005) Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 12:29–33PubMedCrossRef Smidt ML, Janssen CM, Kuster DM, Bruggink ED, Strobbe LJ (2005) Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 12:29–33PubMedCrossRef
13.
go back to reference Soni NK, Carmalt HL, Gillett DJ, Spillane AJ (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964PubMedCrossRef Soni NK, Carmalt HL, Gillett DJ, Spillane AJ (2005) Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 31:958–964PubMedCrossRef
14.
go back to reference Leidenius MH, Vironen JH, Riihela MS, Krogerus LA, Toivonen TS, von Smitten KA, Heikkila PS (2005) The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol 31:13–18PubMedCrossRef Leidenius MH, Vironen JH, Riihela MS, Krogerus LA, Toivonen TS, von Smitten KA, Heikkila PS (2005) The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol 31:13–18PubMedCrossRef
15.
go back to reference Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Early Breast Cancer Trialists’ Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Early Breast Cancer Trialists’ Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed
16.
go back to reference Rutledge H, Davis J, Chiu R, Cibull M, Brill Y, McGrath P, Samayoa L (2005) Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 18:762–768PubMedCrossRef Rutledge H, Davis J, Chiu R, Cibull M, Brill Y, McGrath P, Samayoa L (2005) Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 18:762–768PubMedCrossRef
17.
go back to reference Calhoun KE, Hansen NM, Turner RR, Giuliano AE (2005) Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190:588–591PubMedCrossRef Calhoun KE, Hansen NM, Turner RR, Giuliano AE (2005) Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190:588–591PubMedCrossRef
Metadata
Title
Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications
Authors
Reinou S. Groen
A. Wolter J. Oosterhuis
James E. Boers
Publication date
01-09-2007
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9434-2

Other articles of this Issue 1/2007

Breast Cancer Research and Treatment 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine